Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Apr;15(2):259-261.
doi: 10.3988/jcn.2019.15.2.259. Epub 2019 Mar 11.

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin

Ahwon Kim  1 , Bhumsuk Keam  2 , Hyeon Cheun  3 , Soon Tae Lee  1 , Hyung Seok Gook  1 , Moon Ku Han  4
Affiliations
Case Reports

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin

Ahwon Kim et al. J Clin Neurol. 2019 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

Figures

Fig. 1
Fig. 1. Clinical course of the patient. ABx: antibiotics, ACV: acyclovir, AED: anti-epileptic drug, CRP: C-reactive protein, CSF: cerebrospinal fluid, DWI: diffusion-weighted image, EEG: electroencephalography, FLAIR: fluid-attenuated inversion recovery, GD-enhanced T1: gadolinium-enhanced T1, GTCS: generalized tonic-clonic seizure, IVIG: intravenous immunoglobulin, L: lymphocytes, LCS: lacosamide, LEV: levetiracetam, MDZ CIV: continuous intravenous infusion of midazolam, O: other cells, P: polymorphonuclear cells, PRP: perampanel, TPM: topiramate, VPA: valproic acid, WBC: white blood cells.
See this image and copyright information in PMC

References

    1. Krishnamurthy A, Jimeno A. Atezolizumab: a novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers. Drugs Today (Barc) 2017;53:217–237. - PubMed
    1. Fellner A, Makranz C, Lotem M, Bokstein F, Taliansky A, Rosenberg S, et al. Neurologic complications of immune checkpoint inhibitors. J Neurooncol. 2018;137:601–609. - PubMed
    1. Food and Drug Administration. TECENTRIQ® (atezolizumab) injection, for intravenous use [Internet] USA: Silver Spring: Food and Drug Administration; 2018. [cited 2018 Sep 1]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761034s009lbl.pdf.
    1. Blackmon JT, Viator TM, Conry RM. Central nervous system toxicities of anti-cancer immune checkpoint blockade. J Neurol Neuromed. 2016;1:39–45.
    1. Ito M, Fujiwara S, Fujimoto D, Mori R, Yoshimura H, Hata A, et al. Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient. Ann Oncol. 2017;28:2318–2319. - PubMed